Nikolai Søren Kirkby

No más puestos en curso

Health Technology

Consumer Services

Perfil

Nikolai Søren Kirkby is the founder of Nordic Vaccine A, which was founded in 2001.
He held the title of Chief Scientific Officer from 2009 to 2012.
Dr. Kirkby's former job was as a Principal at the University of Copenhagen.
He received a graduate degree from the University of Copenhagen in 1992 and a doctorate degree in 1995.

Antiguos cargos conocidos de Nikolai Søren Kirkby.

Empresas	Cargo	Fin
University of Copenhagen	Corporate Officer/Principal	-
Nordic Vaccine A/S Nordic Vaccine A/S Pharmaceuticals: MajorHealth Technology Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark.	Fundador	-

Ver el detalle de la experiencia de Nikolai Søren Kirkby.

Formación de Nikolai Søren Kirkby.

University of Copenhagen

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Nikolai Søren Kirkby.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Nordic Vaccine A/S Nordic Vaccine A/S Pharmaceuticals: MajorHealth Technology Nordic Vaccine A/S engages in the development and commercialization of vaccines for prophylactic and therapeutic use. It offers Posintro that combines delivery and immunological properties for the development of prophylactic and therapeutic vaccines. The firm also provides needle free delivery systems, including TransVac, a novel patch system for pain-free, non-invasive, and transdermal delivery of vaccines. The company was founded in 2001 and is headquartered in Copenhagen, Denmark.	Health Technology